← Back to Search

Vascular Closure Device

Persistent A-Fib for Vascular Closure

N/A
Waitlist Available
Research Sponsored by Cardiva Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 days +/- 5 days
Awards & highlights

Summary

A multi-center, prospective, single-arm post market registry, designed to collect both performance and complication outcomes when same day discharge is enabled by the study device, in sealing multiple femoral venous access sites at the completion of ablation procedures for atrial fibrillation with or without another arrhythmia, performed through 6 - 12 Fr inner diameter (maximum 15F OD) introducer sheaths.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 days +/- 5 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 days +/- 5 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Major Complication Rate
VASCADE MVP VVCS Procedure Success
Secondary study objectives
Device Success
Minor Complication Rate
Same Day Procedure Success
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Persistent A-FibExperimental Treatment1 Intervention
Group II: Paroxysmal A-FibExperimental Treatment1 Intervention
Group III: A-FibExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Cardiva Medical, Inc.Lead Sponsor
5 Previous Clinical Trials
1,341 Total Patients Enrolled
~135 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top